Data as of Nov 17, 2026 close · Source: Financial Modeling Prep (methodology)
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Evogene Ltd. (EVGN), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-0.37
P/B ratioShare price divided by book value per share.
-1.28
P/S ratioMarket value divided by annual revenue.
2.27
PEG ratioP/E divided by the earnings growth rate.
0.00
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
0.35
EV / RevenueEnterprise value against annual revenue.
-3.24
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
-232.56%
Free cash flow yieldFree cash flow as a percentage of market value.
-400.90%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
-14.16%
Operating marginRevenue left after operating costs.
-350.00%
Net marginRevenue left after every cost, including tax and interest.
-696.26%
Return on equityProfit as a percentage of shareholders’ equity.
761.97%
Return on assetsProfit as a percentage of total assets.
-67.68%
Return on capital employedOperating profit against the capital the business uses.
-128.22%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
3.57
Quick ratioThe same, excluding inventory.
3.54
Cash ratioCash alone against current liabilities.
4.33
Debt to equityTotal borrowings against shareholders’ equity.
-0.63
Debt to assetsTotal borrowings against total assets.
0.10
Interest coverageHow many times operating profit covers the interest bill.
-2.73
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
−$1.08
Market capitalisationShare price times shares outstanding.
$2.93M
EmployeesReported headcount.
117
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
Evogene Ltd. (EVGN) trades on a price-to-earnings ratio of -0.37. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
What is Evogene Ltd.'s return on equity?
Evogene Ltd. (EVGN) reports a return on equity of 761.97%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Evogene Ltd. carry?
Evogene Ltd. (EVGN) has a debt-to-equity ratio of -0.63, which compares total borrowings with shareholders' equity.
What is Evogene Ltd.'s profit margin?
Evogene Ltd. (EVGN) keeps -696.26% of revenue as net profit after every cost, including tax and interest.